The first quarter of 2021 started very well for EQOLOGY with a growth in turnover of + 55 % in Q1 2021. The Q1 sales was 83,1 MNOK 
(53,6 MNOK). In March, the company reached its second highest sale ever in a month of 29,4 MNOK in sales (19,8 MNOK).

The company has in Q1 2021 continued its commercial development in test based nutrition supplements and further developed its subscription packages towards consumers throughout Europe. The customer and business partner base are increasing rapidly, showing the high demand for health advice and health focus among consumers. The company held 2 large digital events this quarter, in January and March, to further develop its health competence towards business partners and consumers. In Q1, the company also opened 2 new European markets in Spain and Croatia.

The company will during 2021 continue its road to further develop its strategy towards supporting consumers and business partners with premium nutrition supplements, European expansion, innovation in test-based health concepts and digital innovation & transformation. 
    

For questions, contact:

Roar Arnstad
CEO
E-mail: roar.arnstad@eqology.no

Christian Espeseth
Chairman of the board